Learning Objectives:


1.  Review the biology of follicular lymphoma (FL)

2.  Highlight the current treatment paradigm

3.  Discuss a phase ½ clinical trial of obinutuzumab, oral azcitidine (CC-486), and venetoclax in FL



  1. To provide an overview on the current standard of care in the management of advanced upper GI cancers
  2. To discuss the findings of previous phase 1 trials in the treatment of advanced, high risk upper GI cancers

3.    To discuss the design and initial findings of our institutional phase 1 I-FLOAT study

Session date: 
10/14/2021 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kirk Cahill, MD and Koosha Paydary, MD